- Home
- About
- 🤖 AskAnzal AI Advisor
- 📅 Book a Call
- Your Account
- My AskAnzal Account
Over 2,000 real rulings — analysed for what they mean to your team. Published every day.
Showing 1914 cases
A Tillotts Octasa detail aid compared dissolution profiles with Asacol. The Panel ruled the page misleading (Clause 7.2) because it implied clinical…
Ferring was found in breach for late disclosure of one Firmagon trial result (NCT00116753). Other trials were either disclosed on time, outside…
Anonymous employee alleged internal Enstilar launch materials could be seen by visitors and that MSLs reported to sales. Panel found no evidence…
Bayer alleged Mallinckrodt offered contrast injectors as gifts/long-term loans to induce contrast media purchases. PMCPA found the arrangements were bona fide, fair…
Lilly-sponsored oncology handbook listed Vitamin B12 dose as 1g instead of 1mg with Alimta. Panel found inaccurate, misleading content and poor standards;…
Anonymous complaint alleged a Janssen MSL made a health professional uncomfortable by asking them to sign a form to receive CANVAS trial…
Vifor’s Ferinject materials and briefings were found to encourage comparative safety messaging that disparaged Monofer and misled HCPs, including an inaccurate medical…
PMCPA Director case on clinical trial transparency for Tresiba. Most trials were out of UK scope or disclosed on time, but one…
Chiesi’s Fostair NEXThaler banner ad claimed “Efficacy with only 3 steps per inhalation”. PMCPA found it misleading versus the SPC/PIL (breach Clause…
A complaint about alleged off-label promotion at a Xarelto training course was not upheld, but unclear, uncertified training/assessment materials and incorrect quiz…
Complaint alleged Napp-funded pharmacist asthma reviews created a conflict of interest and switched patients to Flutiform. Panel found no evidence to support…
Shire was held responsible for a third-party market research email that amounted to disguised promotion (Revestive) and for inappropriate MSL visit KPIs…
Pfizer’s separate reply-paid card offering an Arthrotec memory stick was treated as standalone promotion and breached the Code because it omitted the…
Sanofi-Aventis’ Lantus mailer drew complaints about cost, hypoglycaemia and weight claims vs Levemir. Cost claim: no breach. Hypoglycaemia headline and weight equivalence…
Roche alleged pre-licence promotion of Tykerb via an international journal ‘teaser’ ad and UK media coverage implying superiority vs Herceptin. Panel found…
Anzal, our PMCPA rulings expert, has knowledge of over 2,000 published cases — ask about precedents, clauses, and how they apply to your situation.
One real case. One key lesson. Every week — free.